Hyperglycemia and Endothelial Dysfunction in Atherosclerosis: Lessons from Type 1 Diabetes

by Steven Daniel Funk, Arif Yurdagul, A. Wayne Orr
Published 2012-01-01

Mechanisms and Consequences of Defective Efferocytosis in Atherosclerosis

by Arif Yurdagul, Arif Yurdagul, Arif Yurdagul, Amanda C. Doran, Amanda C. Doran, Amanda C. Doran, Bishuang Cai, Bishuang Cai, Bishuang Cai, Gabrielle Fredman, Ira A. Tabas, Ira A. Tabas, Ira A. Tabas
Published 2018-01-01

Allosteric MAPKAPK2 inhibitors improve plaque stability in advanced atherosclerosis.

by Lale Ozcan, Canan Kasikara, Arif Yurdagul, George Kuriakose, Brian Hubbard, Michael H Serrano-Wu, Ira Tabas
Published 2021-01-01

Dysregulated oxalate metabolism is a driver and therapeutic target in atherosclerosis

by Yuhao Liu, Ying Zhao, Yousef Shukha, Haocheng Lu, Lu Wang, Zhipeng Liu, Cai Liu, Yang Zhao, Huilun Wang, Guizhen Zhao, Wenying Liang, Yanbo Fan, Lin Chang, Arif Yurdagul, Jr., Christopher B. Pattillo, A. Wayne Orr, Michael Aviram, Bo Wen, Minerva T. Garcia-Barrio, Jifeng Zhang, Wanqing Liu, Duxin Sun, Tony Hayek, Y. Eugene Chen, Oren Rom
Published 2021-07-01